Ionis Pharmaceuticals | IONS - 资产



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 8.86B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


资产 更改 日
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Arrowhead Research USD 2.11B 156.25M 2026-06
Astellas Pharma JPY 3.69T 125.48B 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Celltrion KRW 768.81B 9.37B 2026-03
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Divis Laboratories Ltd INR 200.33B 18.82B 2026-03
Exelixis USD 2.49B 99.36M 2026-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Kangmei Pharma CNY 13.31B 375.64M 2026-03
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 10.96B 527M 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Omeros USD 200.57M 34.59M 2025-06
OPKO Health USD 1.86B 75.15M 2026-03
Organigram Holdings CAD 521.31M 9.36M 2026-03
Ovoca Bio EUR 2.07M 414K 2025-12
Pfizer USD 201.13B 6.49B 2026-06
Pharma Mar EUR 393.6M 8.34M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Qiagen NV USD 5.89B 107.14M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Sartorius EUR 9.6B 270.6M 2026-06
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tilray USD 2.1B 15.95M 2025-09
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06
Zealand Pharma A/S 15.3B 647.8M 2026-03
Zz Pientze Pharmaceu CNY 18.38B 905.93M 2026-03